Search
for
Sort by
Research 30 of 1000+
- Cutaneous signals of immune system disease
- Inactivated COVID-19 Vaccine Induces a Low Humoral Immune Response in a Subset of Dermatological Patients Receiving Immunosuppressants
- Methotrexate/tacrolimus/voriconazole
- The pharmacology of methotrexate
- Markers of inflammation, metabolic disorders, and principles of treatment for alopecia areata in children
- 026 Targeting pathogenic MICA-NKG2D interactions by statins: A novel adjunct treatment strategy for alopecia areata management?
- Dermatological Issues Among Individuals Receiving Palliative Care - A Review
- Immunosuppressive therapy in autoimmune disease — A review
- Acquired epidermodysplasia verruciformis in a heart transplant patient
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Alopecia Areata Associated with Dupilumab: National Database Study
- UTMD Enhances Targeting of Diclofenac and Doxil® to Boost Tumor Immunotherapy
- Clinical Observation of Thyroid Cancer Treated by CAF Regimen Combined with Fufangbanmao Capsule
- Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review
- [Differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma].
- 1112 An innovative phase 1b trial demonstrating proof-of-pharmacology for two novel IRAK4-inhibitors using a local (Imiquimod) and systemic (LPS) driven immune response
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- ROS-scavenging microneedles loaded with <i>Portulaca oleracea</i> L.-derived exosomes for atopic dermatitis therapy
- Green Nanodrugs: Research Progress and Challenges of Plant-Derived Nanovesicles in Tumor Treatment
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- A skin organoid-based infection platform identifies an inhibitor specific for HFMD
- Inhibition of Established Tuberculin Hypersensitivity by Methptrexate,
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
- Engineering immune-competent hair follicle microphysiological systems: from organoid assembly to dynamic immune modelling
- Novel therapies for alopecia areata: The era of rational drug development
- Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata
- Concomitant acute alopecia and profound bone marrow suppression: An unusual manifestation of azathioprine toxicity
- Therapy experience in alopecia after COVID-19